Katz Diagnostics, Inc., founded by renowned rheumatologist Dr. Robert Katz, is developing a biomarker-based test to definitively diagnose fibromyalgia syndrome (FMS). This prevalent disease affects primarily women and is often misdiagnosed, leading to years of pain and expensive testing. A device that diagnoses and monitors the disease can lead to better, non-opioid management and even a cure someday. The company is raising money to develop a prototype for clinical trials to begin in early 2024.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Chicago, Il, Us
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Keywords
- World Business Chicago.
- HQ
- Chicago, IL
Katz Diagnostics, Inc. Questions
Katz Diagnostics, Inc.'s website is http://www.fibromyalgiadiagnostics.com
Katz Diagnostics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/katz-diagnostics-inc
Katz Diagnostics, Inc. has
1 employees.
View email and phone details for 1
employees at Katz Diagnostics, Inc..
Katz Diagnostics, Inc.'s industry is
Medical Equipment Manufacturing
Katz Diagnostics, Inc.'s top competitors are
Next Generation Clinical Research,
Nasa Illinois Space Grant Consortium,
World Business Chicago,
Rheoxtech,
Spaulding Medical,
Empowr3d™,
Glc Aspet,
Qualanex, Llc,
West Therapeutic Development, Llc,
Desifit.
Katz Diagnostics, Inc.'s categories are Medical Equipment Manufacturing
Katz Diagnostics, Inc.'s founding year is 2019
